DanielleKTurgeonMD

PubMed

• 23 citations
  Colonic Mucosal Bacteria Are Associated with Inter-Individual Variability in Serum Carotenoid Concentrations
  Zora Djuric, Christine M. Bassis, Melissa A. Plegue, Jianwei Ren, Rena Chan
  Journal of the Academy of Nutrition and Dietetics. 2017-01-01
• 393 citations
  Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: A randomized placebo-controlled, double-blind trial
  Frank L. Meyskens, Christine E. McLaren, Daniel Pelot, Sharon Fujikawa-Brooks, Philip M. Carpenter
  Cancer Prevention Research. 2008-06-01
• 319 citations
  Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.
  Robert J. Carroll, Richard V. Benya, D.K. Turgeon, Shaiju K. Vareed, Malloree Neuman
  Cancer Prevention Research. 2011-03-01

Journal Articles

• Screening strategies for colorectal cancer in asymptomatic adults  
  Turgeon DK, Ruffin MT 4th, Primary Care, 1/1/2014
• Pilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancer  
  Zick SM, Turgeon DK, Ren J, Ruffin MT, Wright BD, Sen A, Djuric Z, Brenner DE, Molecular Carcinogenesis, 1/1/2014
• Human colonic crypts in culture: Segregation of immunochemical markers in normal versus adenoma-derived  
  Dame MK, Jiang Y, Appelman HD, Copley KD, McClintock SD, Aslam MN, Attili D, Elmunzer BJ, Brenner DE, Varani J, Turgeon DK, Lab Invest, 1/1/2014
• Development of exchange lists for Mediterranean and Healthy Eating Diets: implementation in an intervention trial  
  Sidahmed E, Cornellier ML, Ren J, Askew LM, Li Y, Talaat N, Rapai MS, Ruffin MT, Turgeon DK, Brenner D, Sen A, Djuric Z, The official journal of the British Dietetic Association, 1/1/2013
• A Mediterranean dietary intervention in persons at high risk of colon cancer: Recruitment and retention to an intensive study requiring biopsies  
  Djuric Z, Ruffin MT, Rapai ME, Cornellier ML, Ren J, Ferreri TG, Askew LM, Sen A, Brenner DE, Turgeon DK, Contemp Clin Trials, 1/1/2012
• Phase II Study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal Risk for Colorectal Cancer  
  Zick SM, Turgeon DK, Vareed SK, Ruffin MT, Litzinger AJ, Wright BD, Alrawi S, Normolle DP, Djuric Z, Brenner DE, Cancer Prev Res, 1/1/2011
• Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia  
  Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C, Meyskens FL, Brenner DE, Cancer Prev Res, 1/1/2011
• Possible Role of Meckel's Scan Fused with SPECT CT Imaging: Unraveling the Cause of Abdominal Pain and Obscure-Overt Gastrointestinal Bleeding  
  Turgeon DK, Brenner Darren, Brown Richard K J, Dimagno Matthew J, Case Rep Gastroenterol, 1/1/2008
• Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial  
  Meyskens FL, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, Kelloff G, Lawson MJ, Kidao J, McCracken J, Albers CG, Ahnen DJ, Turgeon DK, Goldschmid S, L..., Cancer Prev Res, 1/1/2008
• Fecal DNA-Based Detection of Colorectal Cancer  
  Turgeon DK, Brenner, DE, Current Colorectal Cancer Reports, 1/1/2007
• Acute hepatitis associated with alosetron (Lotronex)  
  Turgeon DK, Tayeh N, Fontana RJ, J. Clin. Gastroenterol., 1/1/2005
• Colorectal Cancer Screening  
  Nease DE, Stoffel E, Turgeon DK, Ruffin MT, Clinics in Family Practice, 1/1/2003
• Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans  
  Jaffe CA, Turgeon DK, Lown K, Demott-Friberg R, Watkins PB, Am. J. Physiol. Endocrinol. Metab, 1/1/2002
• Molecular and physical mechanisms of first-pass extraction  
  Hall SD, Thummel KE, Watkins PB, Lown KS, Benet LZ, Paine MF, Mayo RR, Turgeon DK, Bailey DG, Fontana RJ, Wrighton SA, Drug Metab. Dispos, 1/1/1999
• Modify lifestyle to reduce chronic heartburn  
  Turgeon DK, The Novi News, The Northville Record, South Lyon Herald, and The Milford Times, 1/1/1997
• Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine  
  Lown KS, Mayo RR, Leichtman AB, Hsiao HL, Turgeon DK, Schmiedlin-Ren P, Brown MB, Guo W, Rossi SJ, Benet LZ, Watkins PB, Clin. Pharmacol. Ther, 1/1/1997
• Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenou...  
  Jaffe CA, Turgeon DK, Friberg RD, Watkins PB, Barkan AL, J. Clin. Endocrinol. Metab, 1/1/1995
• The erythromycin breath test predicts the clearance of midazolam  
  Lown KS, Thummel KE, Benedict PE, Shen DD, Turgeon DK, Berent S, Watkins PB, Clin. Pharmacol. Ther, 1/1/1995
• Screening Recommendations for Colorectal Cancer  
  Turgeon DK, McAuley Cancer Care Center Update, 1/1/1995
• GERD a common problem in both sexes  
  Turgeon DK, The Novi News and The Northville Record, 1/1/1995
• P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients  
  Turgeon DK, Leichtman AB, Lown KS, Normolle DP, Deeb GM, Merion RM, Watkins PB, Clin. Pharmacol. Ther, 1/1/1994
• P450IIIA (CYP3A) activity in severely depressed patients  
  Watkins PB, Turgeon DK, Guthrie SK, Remen AL, Grunhaus L, J Clin Psychopharmacol, 1/1/1993
• Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity  
  Watkins PB, Turgeon DK, Saenger P, Lown KS, Kolars JC, Hamilton T, Fishman K, Guzelian PS, Voorhees JJ, Clin. Pharmacol. Ther, 1/1/1992
• Meckel's diverticulum  
  Turgeon DK, Barnett JL, Am. J. Gastroenterol, 1/1/1990
• Join now to see all

Books/Book Chapters

• Translational Research in Biophotoniccs: Four Case Studies 
  Chapter: Imaging and Biomarker for Early Dectection of Colorectal Cancer 
  Turgeon DK, Joshi BP, Reisdorph B, Wang TDEditors: RJ Nordstrom.SPIE Press, Bellingham, WA2014
• Proteomic and Metabolomic Approaches to Biomarker Discovery 
  Chapter: Serum and Plasma Collection: Preanalytical Variables and Standard Operating Procedures in Biomarker Research 
  Tuck MK, Turgeon DK, Brenner, D.EEditors: Issaq, H.J, Veenstra, T. D.ElsevierEdition 1st,2013
• Jaundice and Abnormal Liver Chemistries 
  Chapter: Gastrointestinal Pathophysiology 
  Turgeon DK. and Moseley R.HEditors: Henderson, J.M..J.B. Lippincott1996
• Textbook of Gastroenterology: Self-Assessment Review 
  Chapter: Self-Assessment Review 
  Turgeon DKEditors: Yamada, T.J.B. LippincottEdition 1st,1993
• Join now to see all

Abstracts/Posters

• Quantitative Targeted Wide Area In Vivo Imaging of Neoplasia in Barrett's Esophagus
  Piraka CR, Chen Y, Duan X, Elmunzer BJ, Kwon RS, Appelman HD, Owens SR, Turgeon DK, Wang TD, DDW 2013 Agenda Book, 5/18/2013
• Sensitivity and Specificity of Fecal Immunochemical and Guaiac Testing for Occult Blood in Archived Frozen Stool Samples
  Nguyen D, Tuck M, Sen, Ruffin IV MT, Baron JA, Bresalier RS, Marcon NE, McConnell D, Stoffel EM, Syngal S, Brenner DE, Turgeon DK, DDW 2012 Agenda Book, 5/19/2012
• Novel Peptide for In Vivo Imaging of Neoplasia in the Esophagus
  Sturm MB, Joshi BP, Piraka CR, Elmunzer BJ, Kwon RS, Appelman HD, Turgeon DK, Wang TD, DDW 2012 Agenda Book, 5/19/2012
• Multicenter Study of a Fluorescence in situ Hybridization Probe Set for the Detection of High Grade Dysplasia and Adenocarcinoma in Barrett's Esophagus
  Poneros JM, Anandasabapathy S, Sen A, Turgeon DK, Syngal S, Bresalier RS, Marcon NE, Stoffel EM, Appelman HD, Brenner DE, Fritcher EB, Halling KC, Gastroenterology, 1/1/2011
• Fluorescence Detection of Colonic Neoplasia Using a Novel Peptide
  Joshi BP, Miller SJ, Komarck CK, Turgeon DK, Appelman HD, Liu Z, Wang TD, Gastroenterology, 1/1/2011
• Validation of targeted detection of dysplasia in Barrett's esophagus with a novel fluorescence-labeled peptide
  Anastassiades CP, Li M, Turgeon DK, Piraka CR, Kwon RS, Elmunzer BJ, Komarck CM, Johnson TD, Appelman HD, Wang TD, Digestive Disease Week, 5/1/2010
• Marked Efficacy of Difluoromethylornithine (DFMO) plus Sulindac in Reducing Recurrent Colorectal Adenomas in Patients with Prior Adenomas: Results of A Randomized, Pla...
  Pelot D, Meyskens FL, Gerner E, McLaren CE, Fujikawa S, Lawson MJ, Kidao J, McCracken J, Griffin R, Albers CG, Carpenter P, Ahnen, DJ, Turgeon, DK, Hagedorn, CH, Gastroenterology, 1/1/2008
• Chromoendoscopic Colonoscopy Detects More Adenomas than Conventional Colonoscopy: A Randomized Trial of Back-to-Back Colonoscopies
  Stoffel EM, Stockwell DH, Normolle D, Tuck M, Marcon D, Turgeon DK, Baron J, Bresalier RS, Syngal S, Brenner D, Gastroenterology, 1/1/2006
• A Randomized Trial of Rofecoxib to Prevent Colorectal Adenomas: the APPROVe Trial
  Bresalier RS, Sandler RS, Bolognese J, Quan H, Oxenius B, Joseph R, Horgan R, Riddell R, Horgan K, Morton D, Lanas A, Baron J, Turgeon DK, Gastroenterology, 1/1/2005
• American Society of Transplant Physicians
  Carlson C, Zimmermann EM, Turgeon DK, Gastroenterology, 1/1/2003
• Hepatic CYP3A4 is the Principal Determinant of Neoral Pharmacokeninetic Variability
  Leichtman AB, Turgeon DK, Blake DS, Rossi S, Walz P.M., and Watkins PB, American Society of Transplant Physicians, 1/1/1997
• Interindividual variation in intestinal mdr1 expression: lack of short term diet effect
  Lown KS, Fontana RJ, Schmiedlin-Ren P, Turgeon DK, Watkins PB, Gastroenterology, 1/1/1995
• Tacrine Hepatotoxicity - The Use of Metabolic Probes to Identify Potential Susceptibility Factors
  Fontana RJ, Turgeon DK, Woolf TF, Knapp MA, Watkins PB, Hepatology, 1/1/1994
• Single Day Oral Phosphate Laxative Preparation for Colonoscopy vs. Intestinal Lavage: Efficacy and Patient Tolerance
  Henderson JM, Barnett JL, Elta GH, Nostrant TT, Turgeon DK, Gastrointestinal Endoscopy, 1/1/1994
• Pulsation Frequency of Growth Hormone May Mediate Gender Differences in CYP3A Activity in Man
  Watkins PB, Turgeon DK, Jaffe CA, Ho PJ and Barkan AL, Journal of Clinical Research, 1/1/1993
• The Erythromycin Breath Test Predicts Appropriate Cyclosporin Dosing in Organ Transplant Recipients
  Turgeon DK, Leichtman AB, Normolle DP, Deeb GM, Merion RM and Watkins PB, Journal of the American Society of Nephrology, 1/1/1992
• The Erythromycin Breath Test Selectively Assays P450IIIA in Patients with Severe Liver disease
  Lown KS, Kolars JC, Turgeon, DK, Merion R, Wrighton SA, Watkins PB, Hepatology, 1/1/1991
• Puritus in Chronic Cholestasis: Observations in the Role of Cytochrome P40IIIA
  Turgeon DK and Watkins PB, The North American Conference of Gastroenterology Fellows, 2/23/1990
• Pruritus in Chronic Cholestasis: Observations on the Role of Cytochrome P450IIIA
  Turgeon DK and Watkins PB, The North American Conference of Gastroenterology Fellows, 1/1/1990
• The Erythromycin Breath Test as a Measure of Liver Function
  Kolars JC, Lown KS, Turgeon DK, Merion RM, Wrighton SA, Watkins PB, Hepatology, 1/1/1990
• Control of the Plasma (K+) in Hyperkalemia: Role of a and b adreno-recepters
  Sterns RH, Izzo Jr. JL, Thomas D, Turgeon DK, Clinical Research, 1/1/1987
• Role of the Adrenergic Nervous System in Hyperkalemia
  Sterns RH, Izzo Jr. JL, Mahany D, Turgeon DK, Kidney International, 1/1/1983
• Join now to see all

Lectures

• Molecular Imaging, Endomicroscopy and Optical Imaging Techniques 
  Chicago, IL - 5/1/2014
• Hepatotoxicity Secondary to Lotronex? 
  Livonia, MI - 10/1/2004
• GERD – The Refractory Refluxer 
  Harbor Springs, MI - 2/1/2003
• Inflammatory Bowel Disease –- New Treatment Options 
  Harbor Springs, MI - 2/1/2003
• Colon Cancer Risk and Prevention 
  Oakland, MI - 4/1/2002
• Colon Cancer Prevention 
  Ann Arbor, MI - 11/1/2001
• Issues in Colon Cancer 
  Novi, MI - 6/1/2000
• Colon Cancer from Soup to Nuts: Epidemiology, Pathogenesis, Risk Factors, Screening and Prevention Strategies 
  Ann Arbor, MI - 2/1/1995
• Join now to see all